Avidity Biosciences
(NASDAQ) RNAM
Avidity Biosciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$18.75M
Net Income (TTM)
$684.63M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RNAM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avidity Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
511
CEO
Sarah Boyce
Website
www.aviditybiosciences.comHeadquarters
San Diego, CA 92121, US
RNAM Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
-40%
Net Income Margin
-37%
Return on Equity
-45%
Return on Capital
-42%
Return on Assets
-35%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$14.60M
Operating Income
$745.94M
EBITDA
$741.79M
Operating Cash Flow
$650.44M
Capital Expenditure
$13.32M
Free Cash Flow
$663.76M
Cash & ST Invst.
$1.70B
Total Debt
$94.56M
Avidity Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$860.00K
-71.1%
Gross Profit
$636.00K
-128.5%
Gross Margin
-73.95%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
511
N/A
Net Income
$237.10M
-131.9%
EBITDA
$252.98M
-110.4%
Quarterly Fundamentals
Net Cash
$1.60B
+7.4%
Accounts Receivable
$12.44M
N/A
Inventory
$0.00
N/A
Long Term Debt
$90.63M
+1432.4%
Short Term Debt
$3.94M
+2.4%
Return on Assets
-34.96%
N/A
Return on Invested Capital
-42.32%
N/A
Free Cash Flow
$175.28M
-68.9%
Operating Cash Flow
$169.77M
-70.0%